Vaccines – Supply of vaccine for active immunisation of adults against lower respiratory tract disease caused by respiratory syncytial virus (RSV)

Summary

The contract concerns the supply of 170,000 doses of vaccine against respiratory syncytial virus for adults during 2026 and 2027 for population immunisation in the Community of Madrid. The vaccines are intended for people aged 80 and over, residents in care homes for older people and people with disabilities aged 60 and over, and people at very high risk. The quantities are estimated and delivery depends on the needs of the Public Health Directorate General.